Suresh Durgam Selected Research

cariprazine

1/2020	Relationship Between Plasma Concentrations and Clinical Effects of Cariprazine in Patients With Schizophrenia or Bipolar Mania.
1/2019	Long-term safety and tolerability of cariprazine as adjunctive therapy in major depressive disorder.
1/2019	Efficacy of cariprazine on negative symptoms in patients with acute schizophrenia: A post hoc analysis of pooled data.
1/2019	Efficacy of cariprazine across symptom domains in patients with acute exacerbation of schizophrenia: Pooled analyses from 3 phase II/III studies.
11/2018	Efficacy of adjunctive low-dose cariprazine in major depressive disorder: a randomized, double-blind, placebo-controlled trial.
1/2018	The safety and tolerability of cariprazine in patients with manic or mixed episodes associated with bipolar I disorder: A 16-week open-label study.
1/2018	Evaluation of the long-term safety and tolerability of cariprazine in patients with schizophrenia: results from a 1-year open-label study.
1/2018	Clinically relevant response and remission outcomes in cariprazine-treated patients with bipolar I disorder.
1/2018	Corrigendum to "Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial" [Schizophr. Res. 176 (2016) 264-271].
12/2017	Global improvement with cariprazine in the treatment of bipolar I disorder and schizophrenia: A pooled post hoc analysis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Suresh Durgam Research Topics

Disease

21	Schizophrenia (Dementia Praecox) 01/2021 - 02/2014
15	Psychomotor Agitation (Akathisia) 11/2018 - 02/2014
14	Major Depressive Disorder (Major Depressive Disorders) 01/2020 - 06/2015
12	Mania (Manias) 01/2020 - 02/2014
8	Nausea 12/2021 - 02/2014
7	Sleep Initiation and Maintenance Disorders (Insomnia) 11/2018 - 02/2014
6	Headache (Headaches) 11/2018 - 02/2015
6	Anxiety Disorders (Anxiety Disorder) 01/2017 - 06/2015
5	Basal Ganglia Diseases (Basal Ganglia Disease) 03/2016 - 02/2014
4	Sleepiness 12/2021 - 10/2016
4	Constipation 11/2018 - 02/2014
4	Tremor (Tremors) 03/2016 - 03/2015
3	Diarrhea 11/2018 - 06/2015
3	Fatigue 11/2018 - 06/2015
3	Body Weight (Weight, Body) 01/2018 - 01/2017
3	Weight Gain 01/2018 - 03/2016
3	Vomiting 01/2017 - 03/2015
3	Dizziness (Lightheadedness) 12/2016 - 02/2014
2	Erectile Dysfunction 12/2016 - 01/2016
2	Ejaculatory Dysfunction 12/2016 - 01/2016
2	Dyspepsia (Indigestion) 03/2015 - 02/2015
1	Nasopharyngitis 11/2018
1	Arthralgia (Joint Pain) 11/2018
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2017
1	Disorders of Excessive Somnolence (Hypersomnia) 10/2016
1	Back Pain (Backache) 03/2016
1	Parkinsonian Disorders (Parkinsonism) 02/2015

Drug/Important Bio-Agent (IBA)

28	cariprazineIBA 01/2020 - 02/2014
11	Dopamine (Intropin)FDA LinkGeneric 01/2019 - 02/2015
9	Vilazodone HydrochlorideIBA 11/2018 - 06/2015
8	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 01/2016
4	5-HT1A Serotonin ReceptorIBA 01/2019 - 06/2015
4	asenapine FDA Link 01/2018 - 10/2016
3	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 12/2016 - 06/2015
2	lumateperoneIBA 12/2021 - 01/2021
2	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2021 - 01/2017
2	Aripiprazole (Abilify)FDA Link 01/2019 - 12/2015
2	LevomilnacipranIBA 01/2019 - 12/2017
2	Antidepressive Agents (Antidepressants)IBA 11/2018 - 03/2016
2	ProlactinIBA 01/2018 - 11/2017
1	Type A Botulinum Toxins (Botox)FDA Link 01/2020
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2019
1	Serotonin (5 Hydroxytryptamine)IBA 01/2019
1	Pharmaceutical PreparationsIBA 11/2017
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2017
1	Olanzapine (Zyprexa)FDA Link 01/2017
1	LithiumIBA 01/2017
1	Dopamine D3 ReceptorsIBA 10/2016
1	LigandsIBA 10/2016

Therapy/Procedure

3	Secondary Prevention 01/2019 - 10/2016
3	Therapeutics 01/2019 - 03/2016
1	Drug Therapy (Chemotherapy) 01/2017